| pubmed-article:17889152 | pubmed:abstractText | Patients with chronic allograft nephropathy (CAN) very frequently suffer anemia. Correction of anemia by means of recombinant erythropoietin (rEpo) is possible and useful, but safety and efficacy must be assessed. | lld:pubmed |
